Mitoguardin2 Is Associated With Hyperandrogenism and Regulates Steroidogenesis in Human Ovarian Granulosa Cells
Open Access
- 28 February 2023
- journal article
- research article
- Published by The Endocrine Society in Journal of the Endocrine Society
- Vol. 7 (5), bvad034
- https://doi.org/10.1210/jendso/bvad034
Abstract
Polycystic ovary syndrome (PCOS) is an endocrinopathy characterized by hyperandrogenism, anovulation, and polycystic ovaries, in which hyperandrogenism manifests by excess androgen and other steroid hormone abnormalities. Mitochondrial fusion is essential in steroidogenesis, while the role of mitochondrial fusion in granulosa cells of hyperandrogenic PCOS patients remains unclear. In this study, mRNA expression of mitochondrial fusion genes mitoguardin1, −2 (MIGA 1, −2) was significantly increased in granulosa cells of hyperandrogenic PCOS but not PCOS with normal androgen levels, their mRNA expression positively correlated with testosterone levels. Dihydrotestosterone (DHT) treatment in mice led to high expression of MIGA2 in granulosa cells of ovulating follicles. Testosterone or forskolin/ phorbol 12-myristate 13-acetate treatments increased expression of MIGA2 and the steroidogenic acute regulatory protein (StAR) in KGN cells. MIGA2 interacted with StAR and induced StAR localization on mitochondria. Furthermore, MIGA2 overexpression significantly increased cAMP-activated protein kinase A (PKA) and phosphorylation of AMP-activated protein kinase (pAMPK) at T172 but inhibited StAR protein expression. However, MIGA2 overexpression increased CYP11A1, HSD3B2, and CYP19A1 mRNA expression. As a result, MIGA2 overexpression decreased progesterone but increased estradiol synthesis. Besides the androgen receptor, testosterone or DHT might also regulate MIGA2 and pAMPK (T172) through LH/choriogonadotropin receptor-mediated PKA signaling. Taken together, these findings indicate that testosterone regulates MIGA2 via PKA/AMP-activated protein kinase signaling in ovarian granulosa cells. It is suggested mitochondrial fusion in ovarian granulosa cells is associated with hyperandrogenism and potentially leads to abnormal steroidogenesis in PCOS.Funding Information
- National Natural Science Foundation of China (81601241)
- Natural Science Foundation of Shandong Province (ZR2021MH056, ZR2016HB31)
- Clinical Medical Science and Technology Innovation Program of Jinan City (201805068)
This publication has 52 references indexed in Scilit:
- Ontogeny of the ovary in polycystic ovary syndromeFertility and Sterility, 2013
- Role of mitochondria in steroidogenesisBest Practice & Research Clinical Endocrinology & Metabolism, 2012
- Mitochondrial Fission Contributes to Mitochondrial Dysfunction and Insulin Resistance in Skeletal MuscleMolecular and Cellular Biology, 2012
- The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its DisordersEndocrine Reviews, 2011
- CYP19 gene: a genetic modifier of polycystic ovary syndrome phenotypeFertility and Sterility, 2010
- Selective expression ofKrasG12Din granulosa cells of the mouse ovary causes defects in follicle development and ovulationDevelopment, 2008
- Tom20 recognizes mitochondrial presequences through dynamic equilibrium among multiple bound statesThe EMBO Journal, 2007
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)Human Reproduction, 2004
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001
- Association of the Steroid Synthesis Gene Cyp11a with Polycystic Ovary Syndrome and HyperandrogenismHuman Molecular Genetics, 1997